AURX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nuo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.25 USD 1.63% Market Closed

Market Cap: $60.5m

	Nuo Therapeutics Inc OTC:AURX	US
	Physicians Realty Trust F:42O	US
	OUE Ltd F:OUE1	SG
V	Vinacomin Viet Bac Mining Industry Holding Corp VN:MVB	VN
E	Exlservice Holdings Inc F:LHV	US
	Trivago NV NASDAQ:TRVG	DE
	Central Japan Railway Co OTC:CJPRF	JP
Y	Yara International ASA DUS:IU2	NO
P	Pilbara Minerals Ltd F:PLR	AU
C	China Pacific Insurance Group Co Ltd XBER:75C	CN

Profitability Summary

Nuo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

64%

Strong 3Y Average Gross Margin

74%

Declining Gross Margin

83% > 64%

Negative Operating Margin

-33%

Negative 3Y Average Operating Margin

-236%

Operating Margin is Increasing

-1 241% > -33%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-234%

Net Margin is Increasing

-1 241% > -39%

Negative Free Cash Flow Margin

-47%

Negative 3Y Average Free Cash Flow Margin

-216%

Free Cash Flow Margin is Increasing

-1 224% > -47%

Exceptional ROE

171%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-423%

ROIC is Increasing

-655% > -148%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.